Skip to main content

Month: February 2024

AITX’s RAD Announces SelectBlur, a Privacy-First Surveillance Video Processing Application

Detroit, Michigan, Feb. 01, 2024 (GLOBE NEWSWIRE) — Robotic Assistance Devices (RAD), a subsidiary of Artificial Intelligence Technology Solutions, Inc. (the “Company”) (OTCPK:AITX), is excited to announce the launch of ‘SelectBlur’, a standalone desktop application designed to enhance privacy and security when distributing and publicizing events captured on video. Set for immediate release, SelectBlur represents RAD’s commitment to innovative, privacy-centric solutions in the security and surveillance industry. SelectBlur is a user-friendly application that allows clients to selectively blur faces in video footage, ensuring the privacy of individuals who are not the focus of the surveillance. The application supports almost any video format and operates entirely on the desktop, eliminating the need for cloud-based...

Continue reading

BTCS Inc. Launches Builder+ to Enhance Ethereum Blockchain Infrastructure

Silver Spring, MD, Feb. 01, 2024 (GLOBE NEWSWIRE) — BTCS Inc. (Nasdaq: BTCS) (“BTCS” or the “Company”), a blockchain technology-focused company, is thrilled to introduce “Builder+”, an innovative extension of our core Ethereum blockchain infrastructure operations, designed to provide scalable revenue growth leveraging our current Ethereum validator operations. “We’ve been heads down and quiet for the latter part of 2023, but we are now excited to share the developments we’ve been working on, such as Builder+,” said Charles Allen, CEO of BTCS. “With Ethereum being the second-largest blockchain, boasting a market cap of over $275 billion, and being integral to our infrastructure operations, we are poised to leverage our extensive expertise in this domain. We believe that the development of scalable revenue streams on Ethereum’s blockchain...

Continue reading

Autonomix Medical, Inc. (NASDAQ: AMIX) to Present at the Virtual Investor New to the Street Event

Live moderated webcast with members of the Autonomix management team on Wednesday, February 7th at 10:00 AM ET THE WOODLANDS, TX, Feb. 01, 2024 (GLOBE NEWSWIRE) — Autonomix Medical, Inc. (NASDAQ: AMIX) (“Autonomix” or the “Company”), a medical device company focused on advancing innovative technologies to revolutionize how diseases involving the nervous system are diagnosed and treated, today announced that it will present at the Virtual Investor New to the Street Event on Wednesday, February 7, 2024 at 10:00 AM ET. As part of the event, Lori Bisson, Chief Executive Officer, Walter Klemp, Executive Chairman, Dr. Robert Schwartz, Chief Medical Officer, and Trent Smith, Chief Financial Officer of Autonomix Medical, will provide a corporate overview and business outlook. In addition to the moderated discussion, investors and interested...

Continue reading

Katapult Announces Double-Digit Preliminary Gross Originations and Revenue Growth for Fourth Quarter 2023

Gross Originations Increase 13% and Revenue Increases ~19% Year-Over-YearResults Exceed Company Outlook PLANO, Texas, Feb. 01, 2024 (GLOBE NEWSWIRE) — Katapult Holdings, Inc. (NASDAQ: KPLT), an e-commerce-focused financial technology company, today announced preliminary gross originations and revenue for the fourth quarter ended December 31, 2023. Based on preliminary unaudited results, Katapult expects to report gross originations of approximately $67.5 million for the fourth quarter, an increase of 13.0% year-over-year and above the 3-5% growth outlook the company provided on November 8, 2023. This is expected to be the fifth consecutive quarter of year-over-year gross originations growth and the second highest level of gross originations volume in the company’s history. Katapult also expects to report approximately $58.0 million...

Continue reading

ITW Reports Fourth Quarter and Full Year 2023 Results

Fourth Quarter 2023 HighlightsRevenue of $4.0 billion, essentially flat Operating margin of 24.8% as enterprise initiatives contributed 150 bps GAAP EPS of $2.38 included $(0.04) impact from the devaluation of Argentina’s currency2023 HighlightsRevenue of $16.1 billion, an increase of 1% with organic growth of 2% Operating income of $4 billion, an increase of 7% Operating margin of 25.1%, an increase of 130 bps GAAP EPS of $9.74, an increase of 6% excluding $0.60 of divestiture gains in 20222024 GuidanceRevenue growth of 2 to 4% with organic growth of 1 to 3% Operating margin of 25.5 to 26.5% with enterprise initiatives contributing approximately 100 bps GAAP EPS of $10.00 to $10.40, a year-over-year increase of 5% at the mid-pointGLENVIEW, Ill., Feb. 01, 2024 (GLOBE NEWSWIRE) — Illinois Tool Works Inc. (NYSE: ITW)...

Continue reading

Teladoc Health to Announce Fourth Quarter 2023 Financial Results

PURCHASE, NY, Feb. 01, 2024 (GLOBE NEWSWIRE) — Teladoc Health, Inc. (NYSE: TDOC), the global leader in whole-person virtual care, announced that it will release fourth quarter 2023 results on Tuesday, February 20, 2024, after the market closes. In conjunction, the company will host a conference call to review results at 4:30 p.m. E.T. on the same day. Conference Call DetailsThe conference call can be accessed by dialing 1-833-470-1428 for U.S. participants and using the access code # 825968. For international participants, please visit the following link for global dial-in numbers: https://www.netroadshow.com/conferencing/global-numbers?confId=60046. A live audio webcast will also be available online at https://ir.teladoc.com/news-and-events/events-and-presentations/. A replay of the call will be available via webcast for on-demand...

Continue reading

Donegal Group Inc. Announces Release Date for Fourth Quarter and Full-Year 2023 Results

MARIETTA, Pa., Feb. 01, 2024 (GLOBE NEWSWIRE) — Donegal Group Inc. (NASDAQ:DGICA) and (NASDAQ:DGICB) announced today that it plans to release its results for fourth quarter and full-year ended December 31, 2023 on Thursday, February 22, 2024, before the opening of regular trading on the NASDAQ Stock Market. The Company will provide a supplemental investor presentation in the Investors section of its website at investors.donegalgroup.com, concurrently with its earnings press release. At approximately 8:30 am ET on Thursday, February 22, 2024, the Company will make available in the Investors section of its website a pre-recorded audio webcast featuring management commentary by Kevin Burke, President and Chief Executive Officer; Jeffrey Miller, Executive Vice President and Chief Financial Officer; and select members of the senior...

Continue reading

CytoDyn Announces Submission of Clinical Protocol to FDA and Initiation of Pre-Clinical Study in Glioblastoma

VANCOUVER, Washington, Feb. 01, 2024 (GLOBE NEWSWIRE) — CytoDyn Inc. (OTCQB: CYDY) (“CytoDyn” or the “Company”), a biotechnology company developing leronlimab, a CCR5 antagonist with the potential for multiple therapeutic indications, announced today that the Company has submitted its revised HIV clinical trial protocol to the FDA. The Company believes this submission will lead to the removal of the clinical hold currently in effect. CytoDyn’s CEO, Dr. Jacob Lalezari stated, “Our HIV protocol has been revised and resubmitted following FDA input, and will study leronlimab in HIV patients who have increased inflammation and immune activation, which causes heart attacks, strokes, and other vascular events. We believe this protocol will help clarify the mechanisms by which leronlimab can be used as an immune...

Continue reading

Black Hills Energy Renewable Resources Completes Acquisition of Renewable Natural Gas Production Facility in Iowa

DUBUQUE, Iowa, Feb. 01, 2024 (GLOBE NEWSWIRE) — Black Hills Corp. (NYSE: BKH) today announced that its nonregulated subsidiary, Black Hills Energy Renewable Resources, completed the purchase of a renewable natural gas production facility in Dubuque, Iowa. The acquisition of the production facility at the Dubuque Metropolitan Area Solid Waste Agency site includes onsite infrastructure and the rights to RNG production at the landfill under a long-term contract. The facility currently injects RNG into the natural gas distribution system serving Dubuque, which is owned and operated by Black Hills Corp.’s regulated natural gas utility in Iowa. “This investment advances our goal to responsibly integrate renewable resources as a component of our overall emissions reduction strategy,” said Todd Jacobs, senior vice president of growth and...

Continue reading

FLINT announces $244 million in New Contract Awards and Renewals

CALGARY, Alberta, Feb. 01, 2024 (GLOBE NEWSWIRE) — FLINT Corp. (“FLINT”) (TSX: FLNT) is pleased to announce that, during the period from November 1, 2023, to January 31, 2024, it has booked new contract awards and renewals that are estimated to generate approximately $244 million in backlog. Approximately 38% of the work will be executed in 2024 with the balance scheduled for 2025-2029. The work will be executed across Energy and Industrial markets, including Oil & Gas (upstream, midstream and downstream), Agriculture and Forestry and will encompass the following services lines: Maintenance, Turnarounds, Construction, Corrosion and Abrasion Wear Technologies and Environmental Services, including abandonment, decommissioning, reclamation and remediation. “We have seen strong bookings to start 2024. We are seeing...

Continue reading

Disclaimer & Cookie Notice

Welcome to GOLDEA services for Professionals

Before you continue, please confirm the following:

Professional advisers only

I am a professional adviser and would like to visit the GOLDEA CAPITAL for Professionals website.

Important Notice for Investors:

The services and products offered by Goldalea Capital Ltd. are intended exclusively for professional market participants as defined by applicable laws and regulations. This typically includes institutional investors, qualified investors, and high-net-worth individuals who have sufficient knowledge, experience, resources, and independence to assess the risks of trading on their own.

No Investment Advice:

The information, analyses, and market data provided are for general information purposes only and do not constitute individual investment advice. They should not be construed as a basis for investment decisions and do not take into account the specific investment objectives, financial situation, or individual needs of any recipient.

High Risks:

Trading in financial instruments is associated with significant risks and may result in the complete loss of the invested capital. Goldalea Capital Ltd. accepts no liability for losses incurred as a result of the use of the information provided or the execution of transactions.

Sole Responsibility:

The decision to invest or not to invest is solely the responsibility of the investor. Investors should obtain comprehensive information about the risks involved before making any investment decision and, if necessary, seek independent advice.

No Guarantees:

Goldalea Capital Ltd. makes no warranties or representations as to the accuracy, completeness, or timeliness of the information provided. Markets are subject to constant change, and past performance is not a reliable indicator of future results.

Regional Restrictions:

The services offered by Goldalea Capital Ltd. may not be available to all persons or in all countries. It is the responsibility of the investor to ensure that they are authorized to use the services offered.

Please note: This disclaimer is for general information purposes only and does not replace individual legal or tax advice.